Vitamin D deficiency: 70% of people have it and most doctors don’t test for it right

If you got a standard blood test recently and your vitamin D came back “normal,” there’s a meaningful chance it wasn’t. The thresholds most labs use to define sufficiency were calibrated primarily against bone outcomes — specifically rickets and osteomalacia, the severe deficiency diseases — not against the full range of things vitamin D does in the body. A level that prevents your bones from crumbling can still leave your immune regulation, hormone synthesis, and cardiovascular function running below optimal.

Meanwhile, over a billion people worldwide have vitamin D levels below what even the conservative thresholds define as sufficient. The latest National Health and Nutrition Examination Survey estimated that roughly 65% of Americans are deficient. In populations with darker skin pigmentation, higher latitudes, or limited outdoor time, the numbers run higher. The problem isn’t obscure. It’s one of the most common nutritional gaps in the industrialized world, it’s been known for decades, and it’s still largely undertreated because the medical establishment can’t agree on what “optimal” actually means.

That disagreement is worth understanding, because it shapes what advice you’ll get and how to evaluate it.


What vitamin D actually is

The name is misleading. Vitamin D isn’t really a vitamin in the conventional sense — it’s a precursor to a steroid hormone. The form produced in your skin from ultraviolet B exposure, or consumed in food and supplements, goes to the liver to be converted into 25-hydroxyvitamin D (25(OH)D), which is the form measured in blood tests. From there it travels to the kidneys for a second conversion into 1,25-dihydroxyvitamin D, the active hormonal form that actually binds to receptors throughout the body.

Those receptors are everywhere. Vitamin D receptors have been identified in virtually every tissue type — not just bones and kidneys, but immune cells, brain tissue, cardiovascular tissue, adipose tissue, the gut. This is why the consequences of deficiency aren’t limited to bone metabolism: when a hormone-like compound is regulating gene expression across dozens of organ systems, running low on it has wide-ranging effects.

Rhonda Patrick has described vitamin D as functioning less like a vitamin and more like a steroid that regulates a substantial portion of the human genome. The most precise version of that is: the active form of vitamin D activates vitamin D response elements on DNA that influence the expression of hundreds of genes involved in immune function, inflammation regulation, calcium metabolism, and much more.


The threshold debate

Here’s where it gets complicated, and where your doctor’s advice might diverge significantly from what researchers in the field actually believe.

The official Endocrine Society guideline from 2011 defined vitamin D deficiency as a blood level below 20 ng/mL, and sufficiency as above 30 ng/mL. That’s the standard most labs and most physicians still use. The 2024 revision moved away from endorsing specific numeric thresholds at all — the panel concluded the evidence base was too uncertain to define cutoffs for disease prevention in healthy people, and recommended against routine testing in most populations.

That retreat from specificity sounds cautious and evidence-based. It mostly is. The large randomized controlled trials the 2024 panel prioritized had a significant problem: many of them enrolled people who weren’t actually deficient to begin with, which means they were testing whether supplementation helps people who already have adequate levels. Unsurprisingly, the effect sizes were small. But testing whether vitamin D supplementation helps vitamin D-sufficient people isn’t the same as testing whether correcting genuine deficiency helps people who are deficient — and the observational and mechanistic data on that question is substantially more compelling.

The functional threshold that makes more physiological sense, based on the PTH suppression data, is around 40–60 ng/mL. Parathyroid hormone, which is a sensitive marker of calcium status and indirectly vitamin D status, continues declining as 25(OH)D levels rise up to roughly 75 nmol/L (30 ng/mL) and stabilizes there. Intestinal calcium absorption increases substantially as 25(OH)D rises to 50–80 nmol/L. Some researchers argue that optimal function — including immune regulation and extraskeletal benefits — requires levels in the 40–60 ng/mL range. This is broadly what Huberman and Rhonda Patrick both target and recommend, with both reportedly taking 5,000 IU of D3 daily to maintain those levels.

The 2024 guidelines were deliberately focused on generally healthy populations without existing deficiency. They’re not saying vitamin D doesn’t matter or that correcting actual deficiency isn’t valuable. They’re saying routine screening in healthy people without risk factors and supplementation beyond the RDA lacks strong RCT-level evidence for disease prevention. Those are different claims, and they get blurred in the popular reporting.


D3 vs D2: not equivalent

This matters more than most people realize, and most generic supplements, including many prescribed by doctors, still use D2.

Vitamin D2 (ergocalciferol) comes from plant and fungal sources. Vitamin D3 (cholecalciferol) is the form synthesized in human skin and found in animal products. They’re both converted by the liver to their respective 25-hydroxy forms, but they don’t perform identically.

A randomized double-blind trial published in Frontiers in Immunology compared gene expression responses to D2 versus D3 supplementation over 12 weeks and found that while both raised circulating 25(OH)D levels, D3 was superior to D2 in the magnitude of that increase — and the immune gene expression changes showed qualitatively different patterns between the two forms. D3 modulated a broader set of immune-relevant genes. The conclusion was that D2 and D3 have overlapping but distinct biological effects, and D3 appears to be the more biologically active form for immune function.

D3 is also more shelf-stable and appears to maintain blood levels more effectively over time. For supplementation purposes, the research consistently supports D3 over D2.


The cofactor problem: why your vitamin D supplement might not be working

This is the most underreported part of the vitamin D story, and it explains why some people supplement faithfully for months and see their levels barely budge.

Magnesium. Every enzyme that activates vitamin D — including the hepatic enzyme CYP2R1 and the renal enzyme CYP27B1 — requires magnesium as a cofactor. Without adequate magnesium, the conversion pathway from supplemental D3 to the active hormonal form is impaired. A 2018 review in the Journal of the American Osteopathic Association concluded that without sufficient magnesium, vitamin D remains stored and inactive for a significant portion of the population.

The scale of the problem: NHANES data suggests up to 79% of U.S. adults don’t meet the recommended daily allowance for magnesium. A GrassrootsHealth study tracking nearly 3,000 participants found that people taking both magnesium and vitamin K2 alongside vitamin D required 244% less vitamin D supplementation to reach the same blood levels as those taking D alone. If your levels aren’t responding to supplementation, magnesium deficiency is a plausible reason.

Not all magnesium forms are equal either. Magnesium oxide, the most common and cheapest form, has poor bioavailability and frequently causes GI distress. Magnesium glycinate (bisglycinate) absorbs significantly better and is gentler.

Vitamin K2. This one is about where calcium ends up. Vitamin D dramatically increases calcium absorption from the gut. That’s the mechanism for supporting bone density. But calcium absorbed into the bloodstream needs to be directed to bone rather than into soft tissue and arterial walls — and that’s K2’s job.

K2 activates two proteins that manage calcium: osteocalcin, which incorporates calcium into bone matrix, and Matrix Gla Protein (MGP), which inhibits calcification of arterial walls. Without K2, the calcium that vitamin D helps you absorb has no directional instruction. Studies in postmenopausal women with osteoporosis found that the D3 + K2 combination produced significantly greater increases in bone mineral density than either compound alone. There’s also ongoing research into whether high-dose vitamin D supplementation without K2 might paradoxically contribute to arterial calcification — the mechanism is plausible even if the human clinical evidence isn’t definitive yet.

The form of K2 matters: MK-7 (menaquinone-7, found in fermented foods like natto) has a longer half-life and better extrahepatic distribution than MK-4. For supplementation purposes, MK-7 is the more studied and generally preferred form.


Why doctors don’t test it right

Most standard panels report 25(OH)D with a normal range that bottoms out at 20 ng/mL and may flag anything above 20 as fine. The lab isn’t making a judgment about your optimal function — it’s flagging severe deficiency using a threshold designed for bone disease prevention in the 1990s.

The 2024 Endocrine Society guideline complicated things further by explicitly recommending against routine 25(OH)D testing in healthy adults, on the grounds that they couldn’t identify specific blood-level targets that translated to measurable disease prevention benefits in RCTs. This is a methodologically defensible position given the trial design problems discussed earlier. It’s also not particularly useful advice for someone who wants to know whether they’re running at an optimal level.

The practical result is that vitamin D testing is becoming less standard in routine checkups, not more, just as awareness of its importance is growing. If you want a meaningful number, you have to ask specifically for a 25(OH)D test and then interpret the result in the context of what the broader research — not just the lab’s reference range — says about optimal function.


Who’s most at risk

The populations with reliably low vitamin D aren’t obscure. People who spend most of their time indoors. People living above approximately 35 degrees north latitude (roughly the latitude of Los Angeles) during winter months, when the sun angle is too low for UVB to reach the skin effectively. People with darker skin pigmentation, where melanin competitively absorbs UVB that would otherwise produce vitamin D — darker skin can require 3–6 times longer sun exposure to produce equivalent vitamin D. People with obesity, where vitamin D is sequestered in adipose tissue and circulating levels run lower than production would suggest. People on medications that accelerate vitamin D catabolism.

The office worker living in the northeastern United States who doesn’t supplement is, by default, likely to be deficient through the winter months and potentially into spring. That’s not a fringe case. It describes most people.


What to actually do

Test your 25(OH)D level. Ask for it specifically. A result below 30 ng/mL warrants correction; results in the 20–40 ng/mL range suggest insufficiency. Whether your target should be the conservative 30 ng/mL or the 40–60 ng/mL range that researchers like Patrick and Huberman recommend is genuinely debated. At minimum, getting above the lab’s “normal” floor and actually into the range where PTH is fully suppressed and calcium absorption is optimized seems reasonable.

Take D3, not D2. Take it with or near the meal that has fat, since it’s fat-soluble and absorption improves substantially with dietary fat.

Check your magnesium status and consider supplementing if you’re in the majority who don’t meet the RDA through diet. Magnesium glycinate is the most tolerated and well-absorbed form for most people.

Add K2 (MK-7 form) if you’re supplementing with meaningful vitamin D doses, particularly anything above 2,000 IU daily. The risk of arterial calcification from high-dose D without K2 isn’t established in controlled trials, but the mechanism is plausible enough and K2 is cheap enough that the cost-benefit calculation is clear.

Don’t megadose without monitoring. Vitamin D toxicity from supplementation is rare, but it does happen — generally at sustained doses above 10,000 IU daily without monitoring blood levels. Toxicity produces hypercalcemia, which is unpleasant and potentially dangerous. Getting a follow-up test 3 months after starting or changing your supplement dose is a reasonable practice that most people skip.

One more thing worth knowing: the morning sun angle changes the calculation. In the summer, at latitudes where the sun gets high enough, 15–20 minutes of midday sun exposure on reasonably large skin areas (arms, legs) can produce more vitamin D than most people take in supplements. The color of the sky at sunset or sunrise has more red and less UVB precisely because the sun angle is low — beautiful light, but not the one that makes vitamin D.


Posted

in

by

Tags:

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *